Skip to content

Comparison of Upper Extremity Function, Physical Activity Levels and Peripheral Muscle Strength, Fear of Movement, Balance, Activities of Daily Living and Quality of Life in Patients With Pacemakers According to Pacemaker Type

Comparison of Upper Extremity Function, Physical Activity Levels and Peripheral Muscle Strength, Fear of Movement, Balance, Activities of Daily Living and Quality of Life in Patients With Pacemakers According to Pacemaker Type

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06775691
Enrollment
60
Registered
2025-01-15
Start date
2024-04-05
Completion date
2026-01-01
Last updated
2026-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Resynchronization Therapy, Implantable Cardioverter Defibrillator, Pacemaker

Brief summary

While research and clinical practice have demonstrated the objective benefits of pacemaker use on mortality, morbidity, and quality of life, some patients do not experience the expected level of improvement following device implantation. The purpose of this research was to determine the effects of device implantation on daily living activities, upper extremity functions, peripheral muscle strength, balance problems, fear of movement and quality of life.

Interventions

None listed

Sponsors

Erol Olcok Corum Training and Research Hospital
Lead SponsorOTHER
Hacettepe University
CollaboratorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* At least 3 months have passed since pacemaker implantation and there are no complications in the last pacemaker control, * Being in NYHA class I-II-III, * Patients with no coordination problems, * Volunteering to participate in the research

Exclusion criteria

* Patients with a history of shoulder pathologies prior to pacemaker implantation that may restrict movement of the upper limb (conditions such as severe pain around the shoulder, edema or shoulder dislocation that may restrict upper limb movement), * Patients with a history of shoulder surgery (limitation in range of motion), * Patients who have had a cerebrovascular event resulting in mastectomy or arm involvement on the affected side, * Patients with decompensated heart failure, * Patients with a history of ICD inappropriate shock, * Those with acute myocardial infarction, * Patients with malignancy on active treatment, patients with collagen tissue disease receiving systemic steroids, * Chronic kidney disease patients on dialysis with unstable volume load

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of activities of daily living1 yearsPerformance Measure for Activities of Daily Living-8 for Patient with Mild Symptomatic Heart Failure- PMADL-8 / The total score ranges from 8-32, with a high score indicating a level of limitation in activities of daily living.
Evaluation of quality of life1 yearsShort Form- 36 -SF-36 / Each sub-parameter is scored between 0 and 100. A high score indicates that the individual has a high quality of life.
Evaluation of upper extremity functional capacity1 years6 Minute Peg Board ve Ring Testi - 6PBRT
Evaluation of peripheral muscle strength1 yearsJamar Hydraulic Hand Dynamometer (Baseline Hydraulic Hand Dynamometer, Model: 12-0240, Fabrication Enterprises INC. White Plains, NY 10602 U.S.A.)
Evaluation of balance1 yearsTime Up and Go Test - TUG
Evaluation of fear of movement1 yearsTampa Scale of Kinesiophobia for Heart- TSK- HEART / The person receives a total score between 17 and 68. A high score on the scale indicates a high level of kinesiophobia.
Evaluation of physical activity levels1 yearsInternational Pyhsical Activity Questionnaire Short Form, IPAQ / It is calculated using the metabolic equivalent method (MET). There are three different categories. The first category is inactive (\<600 MET-minute/week), the second category is minimally active (600-300 MET-minute/week) and the last category is always active (\<3000 MET-minute/week).

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 9, 2026